A 35-year-old woman presents for her first prenatal visit at 12 weeks gestation. She has a family history of Down syndrome, with her sister having a child with the condition. Given her advanced maternal age and family history, the patient is offered first-trimester screening for Down syndrome. The patient undergoes a combined screening test, which includes a nuchal translucency ultrasound and maternal serum screening for pregnancy-associated plasma protein-A (PAPP-A), inhibin-A, and free beta-human chorionic gonadotropin (β-hCG). Which combination of maternal serum markers is most commonly associated with Down syndrome (Trisomy 21)?

A 32-year-old pregnant woman (G2P1) presents for routine prenatal care at 17 weeks of gestation, confirmed by her last menstrual period and an earlier ultrasound. She has no significant medical or genetic history, and her first pregnancy was uncomplicated, resulting in the delivery of a healthy baby. Her family history is also unremarkable for genetic disorders or birth defects. During this visit, she undergoes a second-trimester maternal serum screening (quadruple screen) as part of routine prenatal care. The alpha-fetoprotein (AFP) level is above the 95th percentile. Which follow-up test can confirm the diagnosis of neural tube defects after elevated AFP in maternal serum screening?

A 32-year-old pregnant woman (G2P1) presents for routine prenatal care at 17 weeks of gestation, confirmed by her last menstrual period and an earlier ultrasound. She has no significant medical or genetic history, and her first pregnancy was uncomplicated, resulting in the delivery of a healthy baby. Her family history is also unremarkable for genetic disorders or birth defects. During this visit, she undergoes a second-trimester maternal serum screening (quadruple screen) as part of routine prenatal care. What is the primary marker associated with neural tube defects in maternal serum screening?

Joanna is a 28-year-old woman, currently 20 weeks pregnant with her second pregnancy. Her first pregnancy ended in a miscarriage at 10 weeks. She presents for a routine prenatal care visit. Joanna has no history of chronic illnesses or allergies, and her current pregnancy has been uncomplicated so far. During the visit, Joanna is counseled about the importance of vaccinations during pregnancy. The Tdap vaccine is discussed as essential between 27 and 36 weeks of gestation. Why is the Tdap vaccine specifically administered between 27-36 weeks of pregnancy?

Joanna is a 28-year-old woman, currently 20 weeks pregnant with her second pregnancy. Her first pregnancy ended in a miscarriage at 10 weeks. She presents for a routine prenatal care visit. Joanna has no history of chronic illnesses or allergies, and her current pregnancy has been uncomplicated so far. During the visit, Joanna is counseled about the importance of vaccinations during pregnancy. Which of the following vaccines is universally recommended during pregnancy to protect both the mother and the baby?